One sugary drink a day tracked with 2.45 times the stomach-cancer risk

A daily sugary-drink habit has been associated with a sharply higher relative risk of stomach cancer. The reported study found that consuming more than one sugar-sweetened beverage per day tracked with 2.45 times the gastric-cancer risk. The number is striking, but it describes an association between exposure and outcome, not proof that a particular drink caused any individual case.

What the 2.45-Times Figure Measures

The 2.45-times number belongs to a comparison between consumption groups. Reading it correctly requires keeping the daily exposure category, the relative-risk scale, and the gastric-cancer outcome together.

The core result compares gastric-cancer risk across different levels of sugar-sweetened beverage consumption. More than one such drink each day was associated with 2.45 times the risk, according to the study summary. That is a relative comparison. It indicates how the measured groups differed from one another, but it does not reveal the absolute chance of developing the disease without the underlying event counts.

Relative figures can communicate the strength of an association while still leaving important context unstated. A multiplication of risk is not the same as saying that 2.45 out of every hundred consumers will develop stomach cancer. It also does not show that every person with the higher exposure faces the same risk. The finding is best read as a population-level signal tied to a defined consumption pattern.

“Tracked With” Is the Crucial Phrase

An observational association cannot by itself establish cause and effect. People who consume different amounts of sugary drinks may also differ in other ways that affect health. A study can account for known differences, but the reported finding still remains an association. The wording “tracked with” preserves that limit and keeps the 2.45 figure from becoming a claim that sugary drinks were proven to produce stomach tumors.

That limitation does not make the signal meaningless. A large relative difference can justify closer attention, replication, and investigation of possible mechanisms. The right question is whether the pattern remains consistent across analyses and populations, not whether one result settles the subject. Association provides a reason to investigate; causation requires a broader and more convergent body of evidence.

Daily Exposure Makes the Pattern Relevant

The exposure threshold in the report was more than one sugar-sweetened beverage per day. That detail matters because it describes a repeated habit rather than an occasional drink. Frequency can help distinguish a persistent dietary pattern from sporadic consumption, although the finding does not establish whether risk changes evenly at every intake level or whether a specific threshold exists.

The category also matters. “Sugar-sweetened beverage” is broader than any single brand or flavor. The result concerns the measured class of drinks and cannot be used to rank particular products without additional evidence. Likewise, the finding does not show that replacing one drink automatically eliminates risk. It identifies a consumption pattern associated with a difference in gastric-cancer outcomes.

Risk Comparisons Need an Absolute Baseline

A relative-risk figure gains practical meaning when paired with the baseline rate in the comparison group. The report provides the 2.45-times association but not an absolute-risk figure. Without that denominator, the result should not be converted into a personal probability. The direction and magnitude of the relationship can be described, while the number of additional cases remains outside the available evidence.

This is a common challenge in health headlines. Multipliers are easy to understand as “higher,” but they can sound like a forecast for a particular person. Population studies instead describe patterns across groups. Individual risk can be shaped by many factors that the single statistic does not summarize. Accurate communication keeps the group comparison intact and avoids turning it into a diagnosis.

Where the Evidence Points Next

The result supports several lines of further inquiry. Researchers can test whether the association appears in other populations, whether it changes across consumption levels, and which characteristics of the beverage pattern might be relevant. They can also examine whether the relationship persists after different analytical adjustments. None of those questions is answered merely by repeating the relative-risk number.

For now, the most defensible conclusion is specific. In the reported analysis, consuming more than one sugar-sweetened beverage each day was associated with 2.45 times the risk of gastric cancer. That is a meaningful warning signal and a reason for continued study. It remains an association, and the available evidence does not support claims about a guaranteed outcome, an exact personal probability, or a proven causal pathway.

The measurement also leaves the meaning of “one a day” tied to the study’s exposure category rather than a universal biological boundary. The finding says more than one daily beverage was associated with the higher risk; it does not show that risk abruptly changes after a precise serving or that all serving sizes are equivalent. A stronger dose analysis would compare several intake levels and report their absolute outcomes.

Health evidence is most useful when a memorable number keeps its denominator and design attached. Here, the multiplier belongs to a comparison between consumption groups, not to every can or glass. Repeating the 2.45 figure without that context would exaggerate certainty. Retaining the association language allows the result to inform future work while preventing a population pattern from becoming an unsupported personal prediction.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

More from Morning Overview